Abbott Laboratories 

€11.9
3730
+€0.3+2.59% Today

Statistics

Day High
11.9
Day Low
11.8
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
20.69B
P/E Ratio
-
Dividend Yield
18.32%
Dividend
2.18

Upcoming

Dividends

18.32%Dividend Yield
Feb 26
€0.54
Nov 25
€0.51
Aug 25
€0.51
May 25
€0.52
Feb 25
€0.57
10Y Growth
9.25%
5Y Growth
6.96%
3Y Growth
7.3%
1Y Growth
6.78%

Earnings

22AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
1.07
1.21
1.36
1.5
Expected EPS
1.153064
Actual EPS
N/A

Financials

32.28%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
79.59BRevenue
25.69BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABL0.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson competes with Abbott in multiple segments including medical devices, diagnostics, and pharmaceuticals, making it a direct competitor across several of Abbott's business lines.
Medtronic
MDT
Mkt Cap116.33B
Medtronic competes with Abbott in the medical devices sector, particularly in cardiovascular and diabetes care products.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific competes with Abbott in the diagnostics and life sciences sector, offering a range of analytical instruments, reagents, and consumables.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation competes with Abbott in the diagnostics and life sciences industry, particularly through its subsidiary Cepheid, which offers molecular diagnostics solutions.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific competes with Abbott in the medical devices sector, especially in cardiovascular products.
Baxter International
BAX
Mkt Cap9.49B
Baxter International competes with Abbott in the medical devices and nutrition sectors, offering products for critical care, nutrition, renal care, and more.
Stryker
SYK
Mkt Cap136.19B
Stryker competes with Abbott in the medical devices sector, particularly in orthopedics, which indirectly competes with Abbott's offerings in other medical device categories.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company competes with Abbott in the medical technology sector, offering devices, laboratory equipment, and diagnostic products.
Resmed
RMD
Mkt Cap36.04B
ResMed competes with Abbott in the health sector by providing medical devices for sleep disorders and respiratory conditions, which complements Abbott's broader medical device portfolio.
Hologic
HOLX
Mkt Cap16.45B
Hologic competes with Abbott in the diagnostics sector, particularly in women's health, where both companies offer a range of diagnostic and medical imaging solutions.

About

Absolute Software Corporation develops, markets, and provides cloud-based endpoint visibility and control platform for the management and security of computing devices, applications, and data for enterprise and public sector organizations. The company offers the Absolute platform to provide the connectivity, visibility, and control of data and devices of the operating system; to recover automatically to a secure operational state without user intervention; to support various other security controls and productivity tools from decay and vulnerabilities; and to enable measurement of the health, compliance, and state of decay of endpoint security controls and productivity tools, as well as for reporting and analytics, geotechnology, and endpoint investigation and recovery applications. It also provides professional, technical support, and investigation services. The company markets its solutions through device original equipment manufacturers, distributors, and value added resellers, as well as directly to corporations, government entities, educational institutions, financial services, healthcare sectors, and consumers. It operates in North America, Europe, and Africa, as well as the Asia-Pacific and Latin American regions. Absolute Software Corporation was founded in 1993 and is headquartered in Vancouver, Canada.
Show more...
CEO
ISIN
CA0028221046
WKN
000A417NR

Listings

0 Comments

Share your thoughts

FAQ

What is Abbott Laboratories stock price today?
The current price of ABL0.F is €11.9 EUR — it has increased by +2.59% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
What is Abbott Laboratories stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abbott Laboratories stocks are traded under the ticker ABL0.F.
What is Abbott Laboratories market cap?
Today Abbott Laboratories has the market capitalization of 20.69B
When is the next Abbott Laboratories earnings date?
Abbott Laboratories is going to release the next earnings report on April 22, 2026.
What were Abbott Laboratories earnings last quarter?
ABL0.F earnings for the last quarter are 1.28 EUR per share, whereas the estimation was 1.27 EUR resulting in a +0.29% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Abbott Laboratories revenue for the last year?
Abbott Laboratories revenue for the last year amounts to 79.59B EUR.
What is Abbott Laboratories net income for the last year?
ABL0.F net income for the last year is 25.69B EUR.
Does Abbott Laboratories pay dividends?
Yes, ABL0.F dividends are paid quarterly. The last dividend per share was 0.06 EUR. As of today, Dividend Yield (FWD)% is 18.32%.
When did Abbott Laboratories complete a stock split?
Abbott Laboratories has not had any recent stock splits.